Shenzhen YHLO Biotech Co Ltd

688575

Company Profile

  • Business description

    Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.

  • Contact

    Baolong 2nd Road, Baolong Street
    Building 1, Yahuilong Biotechnology Factory Area
    Longgang District
    Guangdong Province
    Shenzhen518116
    CHN

    T: +86 75584821649

    https://www.szyhlo.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    1,664

Stocks News & Analysis

stocks

This ASX share just lost its moat

We revisit our long-term earnings assumptions and thesis.
stocks

ASX gold miner overvalued despite stronger gold prices

Higher gold prices boosted profit yet shares remain materially overvalued.
stocks

ASX energy giant undervalued despite commissioning challenges

Near-term hurdles, long-term upside.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,198.3029.300.32%
CAC 408,458.7852.720.63%
DAX 4025,464.01102.980.41%
Dow JONES (US)52,747.32537.241.03%
FTSE 10010,871.0289.270.83%
HKSE25,625.38314.531.24%
NASDAQ24,876.9155.17-0.22%
Nikkei 22561,299.401,065.52-1.71%
NZX 50 Index13,976.67114.740.83%
S&P 5007,428.7815.600.21%
S&P/ASX 2009,036.6033.100.37%
SSE Composite Index3,831.0817.770.47%

Market Movers